GleamWall
中文EN

RVP RETRACTABLE TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 946563 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY5.3%
TTM EPS YoY4.5%
Revenue 3-yr CAGR-3.3%
Net income 3-yr CAGR—

Margins

Gross margin-5.2%
Operating margin-61.1%
Net margin-16.1%
FCF margin—
EBITDA margin-40.4%

Returns

ROE-8.3%
ROA-4.3%
ROIC (approx.)-25.6%
Asset turnover0.27x

Leverage & solvency

Liabilities / assets49.2%
Debt / equity0.00x
Current ratio4.54x
Interest coverage-299.43x

Cash quality & payout

Operating cash flow / net income0.65x
Accruals ratio-1.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$14.13M$7.20M$7.18M$9.44M$10.09M$10.45M$8.30M$9.07M
Cost of revenue$13.93M$7.01M$8.02M$10.97M$8.40M$10.55M$8.30M$11.57M
Gross profit$193,247$190,852-$838,408-$1.53M$1.69M-$107,090-$1,911-$2.49M
R&D expense$147,535$187,291$170,416$124,864$199,462$160,049$191,192$157,894
SG&A expense$2.99M$3.61M$3.43M$3.13M$3.56M$3.20M$2.88M$3.38M
Operating income-$4.14M-$5.15M-$6.17M-$7.71M-$3.65M-$5.13M-$4.68M-$7.22M
Interest expense$16,618$18,705$20,441$21,609$20,585$22,257$23,455$26,711
Pretax income-$2.36M$2.83M-$4.22M-$2.35M$372,740-$85,657-$10.21M$3.77M
Income tax$1,346$1,837$1,837$2,024$1,693$1,814$285,761$1,990
Net income-$2.36M$2.83M-$4.23M-$2.35M$371,047-$87,471-$10.50M$3.77M
EBITDA-$2.24M-$3.25M-$4.26M-$5.57M-$1.79M-$3.26M-$2.79M-$5.33M
EPS (basic)-0.080.09-0.14—0.010.00-0.35—
EPS (diluted)-0.080.09-0.14—0.010.00-0.35—
Weighted avg. shares (diluted)29.94M29.94M29.94M—29.94M29.94M29.94M—
Balance sheet
Cash & equivalents$1.89M$2.64M$2.77M$2.59M$3.44M$3.04M$3.38M$4.24M
Receivables$14.31M$9.03M$6.98M$7.90M$8.44M$8.09M$5.36M$7.79M
Inventory$10.12M$15.93M$16.43M$17.19M$20.39M$20.45M$21.18M$19.19M
Current assets$64.64M$65.92M$59.96M$63.08M$64.13M$63.00M$63.66M$73.27M
PP&E, net$73.65M$75.47M$77.31M$79.18M$82.24M$84.01M$85.55M$87.35M
Total assets$138.55M$141.69M$137.60M$142.63M$146.43M$147.09M$149.31M$160.72M
Current liabilities$14.23M$13.37M$10.45M$9.60M$9.63M$8.99M$9.50M$8.78M
Short-term debt————$359,102$349,962$343,216$332,480
Long-term debt———$895,645$623,605$717,530$807,390$900,042
Total debt———$895,645$982,707$1.07M$1.15M$1.23M
Total liabilities$68.10M$68.83M$67.50M$68.26M$69.65M$70.62M$72.70M$73.55M
Shareholders' equity$70.45M$72.87M$70.09M$74.38M$76.78M$76.47M$76.61M$87.17M
Net debt———-$1.69M-$2.46M-$1.98M-$2.23M-$3.00M
Shares outstanding29.94M29.94M29.94M29.94M29.94M29.94M29.94M29.94M
Cash flow statement
Operating cash flow-$248,232-$1.73M-$1.37M-$596,542-$1.26M-$3.73M-$1.48M-$1.10M
Capital expenditure$53,566$29,823$6,227—$89,788$332,250$87,034$298,058
Free cash flow-$301,798-$1.76M-$1.37M—-$1.35M-$4.07M-$1.56M-$1.40M
Investing cash flow-$326,455$1.81M$1.69M-$114,698$1.80M$3.54M$762,239$1.56M
Financing cash flow-$175,440-$198,146-$146,823-$144,673-$142,396-$140,725-$139,527-$136,996
Depreciation & amortization$1.90M$1.90M$1.90M$2.14M$1.87M$1.87M$1.88M$1.89M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.